Akero Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2018 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Akero Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2018 to Q1 2023.
  • Akero Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2021-08-13
Q3 2019 $0 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $0 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-12
Q3 2018 $0 Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $0 Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.